GLP-1
Data presented at the virtual American Diabetes Association meeting has Pfizer excited about the promise of its GLP-1R Agonist PF-06882961.
Philadelphia, PA – Oncoceutics announced a Brown University award of $3.4 million that will be used to support a group of research teams for preclinical research, IND-enabling studies and a first-in-human clinical trial for Oncoceutics’ imipridone ONC212.
Diabetes and obesity remain a problem, even during a pandemic. Eli Lilly is continuing to develop the 13 diabetes drugs it has in Phase I through Phase III trials, with data from various trials planned for release throughout the coming year.
Completes concurrent financing of ~$22 million led by Orbimed Advisors, LLC
Award-winning Australian bioanalytical laboratory Agilex Biolabs announced it has expanded its lab facilities by more than 30% to accommodate demand, mainly from US and APAC-based biotech companies.
In a statement issued to the Boston Business Journal, Intarcia expressed both disappointment and a determination to get an approval for ITCA 650.
Researchers with City of Hope have developed a chimeric antigen receptor (CAR) T cell therapy leveraging chlorotoxin, a component of scorpion venom.
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations.
Biotage AB, is pleased to announce the launch of a Good Laboratory Practices software upgrade for Biotage® Extrahera™, their flagship automated sample preparation instrument for Supported Liquid Extraction, Solid Phase Extraction, Phospholipid Depletion and Protein Precipitation.
Clarivate Analytics has pegged 11 drugs set to enter the market this year as potential blockbusters by 2024, meaning each will achieve annual sales of more than $1 billion.
PRESS RELEASES